Spinal Cord Injury Navigator Intervention: Bridging Gaps in the Prevention and Management of Pressure Injuries

November 17, 2026 updated by: Denise Fyffe, Kessler Foundation

The goal of this study is to compare the efficacy, feasibility and acceptability of implementing a standard pressure injury education program with a patient navigation program designed to provide information and support to wheelchair users living with a spinal cord injury prevent and manage pressure injuries.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Pressure injuries are a critical problem for people living with SCI. Interventions, like SCI Navigation, can provide education and supportive resources which have been found to support the prevention and management of pressure injuries for wheelchair users with SCI. Self-management support interventions are promising in community settings, but adherence is challenged by social drivers of health, non-medical factors that make it difficult for people with SCI to implement their self-management strategies in "real life".

Patient navigation is an intervention approach that provides community-based support to address both medical and non-medical factors that drive success or failure in pressure injury management and prevention.

However, the best ways to coordinate and deliver SCI Navigation services for wheelchair users with SCI are not well understood. This project will compare two programs providing education and support to individuals living with SCI to prevent and manage the complex nature of pressure injuries.

Objective 1: Evaluate the feasibility and acceptability of the SCI Navigator Program in the prevention and management of pressure injuries for community-dwelling wheelchair users living with SCI.

Objective 2: Demonstrate that the SCI Navigator Program promotes positive change in healing progress (PUSH 3.0) and lower risk (Braden Scale) of pressure injuries among people with community-dwelling wheelchair users living with SCI.

Objective 3: Test the long-term effects of the SCI Navigator Program primary outcomes (positive change in the healing progress and lower risk of pressure injuries) and secondary outcomes (pressure injury knowledge, confidence in pressure injury self-management skills, lifestyle behaviors, and quality of life) among community-dwelling wheelchair users living with SCI at 6-, and 12-months post-intervention.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Are at least 18 years of age.
  • At least 1 year post injury.
  • Have a current pressure injury (stage/grade I - IV).
  • Use a manual or power wheelchair as their primary means of mobility.
  • Are living in the community.
  • Speak and understand verbal and written English.
  • Are able to provide informed consent independently.

Exclusion Criteria:

  • I am currently hospitalized or living in a long-term care facility.
  • I have a medical diagnosis of cognitive impairment that affects decision making capacity (such as traumatic brain injury).
  • I am living with an SCI due to malignancy.
  • I have a condition that is expected to get worse over time (such as Parkinson's Disease, Alzheimer's disease).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individualized Navigation Program

Structured Education Program

Participants in this arm will communicate with the Navigator monthly by phone, in-person or via Zoom. The Navigator will help me identify my barriers and goals related to living with a SCI and pressure injury management, as well as provide education and resources.

Active Comparator: Structured Education Program

Participants in this arm of the study, the Navigator will communicate with participants monthly by phone or via Zoom. The Navigator will provide participants with structured education to support the prevention and management of pressure injuries. These calls may last between 60 - 90 minutes.

In the other program, the Navigator will communicate with me monthly by phone or via Zoom. The Navigator will provide me with structured education to support the prevention and management of pressure injuries. These calls may last between 60 - 90 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Ulcer Scale for Healing (PUSH Tool 3.0)
Time Frame: 12 months post enrollment

A measure of wound healing indicated by a change in score, with scores ranging from 0 to 17, where "0" = healed and "17" is a severe unhealed wound.

12 months post enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Denise Fyffe, PhD, Kessler Foundation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

March 30, 2029

Study Completion (Estimated)

November 30, 2029

Study Registration Dates

First Submitted

November 13, 2026

First Submitted That Met QC Criteria

November 17, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 17, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • E-1322-26
  • CSCR26IRG021 (Other Grant/Funding Number: State of New Jersey Commission on Spinal Cord Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All individual participant data (IPD) will be shared via the Interuniversity Consortium for Political and Social Research (ICPSR). Data shared via ICPSR will include data from measures collected at baseline and follow-ups for purposes of sample characterization and/or outcomes assessment. All data will be de-identified and labeled with subject identification numbers established for the study rather than names or initials.

IPD Sharing Time Frame

Data will be made available within 6 to 12 months of the completion of the study and will remain available indefinitely.

IPD Sharing Access Criteria

Data will be made available within 6-12 months of the completion of the study and will remain available indefinitely.

Requests for data access will be coordinated through the Interuniversity Consortium for Political and Social Research (ICPSR) according to their established procedures.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.